IRCT20190727044343N1已完成3 期
The effect of febuxostat against lung injury induced by COVID-19 virus in infected patients: A clinical trial study
Mazandaran University of Medical Sceinces0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit(—)
- 性别
- All
入选标准
- •Patients infected with COVID-19
排除标准
- •Severe disease patients that need hospitalization.
研究者
相似试验
尚未招募
Unknown
to evaluate efficacy of lung boost device to improve lung functioning in patients having pleural effusioCTRI/2023/05/053024Ravi Nair Physiotherapy College
尚未招募
不适用
Effect of airway clearance device on function and quality of life in stable ICU patients.CTRI/2022/12/048008MGM College of Physiotherapy
尚未招募
不适用
Effects of newer injectable medication (biological agents) on respiratory function, exercise capacity and sleep quality in patients with bad uncontrolled asthmaCTRI/2022/10/046458Dr Randeep Guleria
进行中(未招募)
1 期
Beta Agonist Lung injury Trial - Prevention Study - BALTI PreventioEUCTR2007-004096-19-GBBirmingham Heartlands Hospital360
已完成
不适用
The effect of prophylactic bronchodilator treatment with transdermal tulobuterol patch on lung compliance and airway resistanceDiseases of th respiratory systemKCT0001152Pusan National University Hospital82
